June is HHT Awareness Month, a time to raise awareness of hereditary hemorrhagic telangiectasia (HHT), a genetic disorder affecting the blood vessels. Because HHT is a complex genetic disease that affects multiple organ systems, it needs to be understood by radiologists who play a key role in diagnosis and therapy. In May, a team of experts from the UC San Francisco Departments of Radiology and Biomedical Imaging and Pediatrics wrote a review published in Radiology.
“International clinical guidelines were recently published in the Annals of Internal Medicine prompting a detailed discussion of the role of imaging and image-guided therapy in HHT,” says Steven Hetts, MD, corresponding author of this review and co-director of the UCSF HHT Center of Excellence with Miles Conrad, MD, MPH. Michael Ohliger, MD, PhD, associate professor of in the Abdominal Imaging section at…